MAZ and hepatocellular carcinoma: In summary, our findings suggest that a unique MAZ-OTUB1-RACK1-PI3K/AKT and FAK/ERK axis plays a critical role in the progression of HCC and that blocking this axis may be an advantageous therapeutic strategy for curing HCC.